General Information
Get notified when AxoSim moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Discover More
United States Market
Biopharma
About AxoSim
Taxonomy: Drug Development, Preclinical Testing, Neurotoxicity, Neuroefficacy, 3D Cell Assays, Neurodegenerative Disease Models, Myelination Models, Nerve-on-a-Chip, Organ-on-a-Chip, Peripheral Neuropathy, Toxicology, Neuroscience, Organoids
Funding Rounds & Investors (11)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | - | 10 Jun 2021 | |
| Series A | •••••• | 1 |
|
28 May 2021 |
| Private Equity Round | •••••• | 2 |
|
05 Nov 2020 |
| Seed Round | •••••• | 1 |
|
01 Jun 2019 |
| Venture Round | •••••• | 1 |
|
07 Mar 2019 |
AxoSim Alternatives & Competitors
Better Human Disease Models
FAQ About AxoSim
Don't just browse. Track.
Signal Tracker monitors AxoSim and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.